VISEN Pharmaceuticals

HK$13.28As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2561Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (31.37%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM (65.07%)
Mkt cap HK$1.451B
ROIC (16.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$16
18.36%
(38.71%)
Hold 4|8|10|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.21
0.22
0.22
0.23
16.77%
24.34%
21.17%
17.81%
Revenue¥M
152.1
148.1
156.9
164.7
(2.16%)
(5.58%)
0.65%
5.57%
Peers (US$185.1M)
Cap (US$)
PE
167.8M
6.517x
Capital
TTM
5Y
10Y
Leveragex
0.804
0.263
0.270
EBIT/Intx
1.456
0.384
0.377
Own earn%
(73.81)
44.54
43.75
Sh yield%
10.72
21.63
20.57
Owners
Insiders/Inst%
14.62
82.29
Short interest%
3.37
SBC / revenue%
0.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
4–11
$1 testx
0.1
Incr. ROIC%
1